The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Book Review
PreviousPrevious
Volume 338:1632-1633 May 28, 1998 Number 22
NextNext

Therapy of Systemic Rheumatic Disorders

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
Edited by Leo B.A. Van de Putte, Daniel E. Furst, H. James Williams, and Piet L.C.M. van Riel. 709 pp. New York, Marcel Dekker, 1998. $225. ISBN 0-8247-9516-4.

A generation ago, in the 1960s, many exciting developments were taking place in rheumatology. Clinical studies were greatly improving the classification of the systemic rheumatic diseases, basic research was elucidating the immune system and its central involvement in the pathogenesis of many diseases, and controlled clinical trials were beginning to validate the effectiveness of some treatments. During the ensuing two decades there were few important therapeutic advances. Now, rheumatology may be on the threshold of a new era with the emergence of specific biologic agents that target selected cell-surface antigens and proinflammatory cytokines and the development of strategies in which . . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.